Cefpodoxime Proxetil Granule, For Suspension
Product Images NDC 16714-402

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Cefpodoxime Proxetil (NDC 16714-402). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (50 mg/5 mL (50 mL Bottle))

Package Label-principal Display Panel (50 mg/5 mL (50 mL Bottle))
Cefpodoxime Proxetil is a medication for oral suspension. It comes in a bottle of 50 mL when constituted and each 5 mL contains 50 mg of cefpodoxime. The usual dosage is indicated in the package insert. This medication is not for injection and should be stored at 20-25°C before reconstitution and 2-8°C after constitution. Before reconstitution, remove the desiccant capsule and discard it. To mix, shake the bottle to loosen granules and add required water. The mixture can be used for 14 days after which unused portions should be discarded. This medication should be kept away from children. The manufacturer is Aurobindo Pharma Limited in India and it is packaged by Northstar Rx LLC in Memphis, TN.*
FDA Label Image

Package Label-principal Display Panel (50 mg/5 mL Carton Label)

Package Label-principal Display Panel (50 mg/5 mL Carton Label)
Cefpodoxime Proxetil for Oral Suspension is a medication used for treating different types of bacterial infections. It comes in the form of granules that need to be mixed with water before use, resulting in 50 mL of bacterial killing power when completely constituted. Each 5 mL of suspension contains cefpodoxime proxetil equivalent to 50 mg cefpodoxime. It is important to keep the constituted suspension in a refrigerator between 2° to 8°C for a longer shelf life. The usual dosage instructions are present in the package inserts, and it is not suitable for injection. It is manufactured in India, and Northstar Rx LLC from Memphis, TN 38141 market and distribute it.*
FDA Label Image

Package Label-principal Display Panel (100 mg/5 mL (50 mL Bottle))

Package Label-principal Display Panel (100 mg/5 mL (50 mL Bottle))
Each 5 mL of suspension contains 100 mg of cefpodoxime proxetil. This medicine is not for injection and should be stored at 20-25°C. Before use, the desiccant capsule should be discarded and the bottle should be shaken. The mixture can be used for 14 days and should be kept in a refrigerator. This medicine is for oral suspension only and should be kept out of children's reach. Dosage instructions can be found on the package insert. Manufactured by Aurobindo Pharma Limited in India for Northstar Rx LLC.*
FDA Label Image

Package Label-principal Display Panel (100 mg/5 mL Carton Label)

Package Label-principal Display Panel (100 mg/5 mL Carton Label)
This is a description of Cefpodoxime Proxetil oral suspension, a medication used to treat infections caused by bacteria. It contains 100 mg of cefpodoxime proxetil per mL, and comes in a 50 mL bottle when constituted. The text provides information on proper storage, dosage, and administration, including directions for mixing and instructions to discard unused portions after 14 days. It also warns that the medication is not for injection and should be kept out of reach of children. The medication is manufactured by Aurobindo Pharma Limited in India, and distributed by Northstar Rx LLC in Memphis, TN.*
FDA Label Image

Chemical Structure (Cefpodoxime Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.